Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palliative RadIotherapy of Multiple Metastatic Sites Before First Line of Systemic Therapy With Immune Checkpoint Inhibitors and Chemotherapy in Metastatic Non-Small-Cell Lung Cancer (PRIMM Study)

NCT05440916 is registered in ClinicalTrials.gov with University Medical Centre Maribor as lead sponsor.

NCT NCT05440916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05440916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palliative RadIotherapy of Multiple Metastatic Sites Before First Line of Systemic Therapy With Immune Checkpoint Inhibitors and Chemotherapy in Metastatic Non-Small-Cell Lung Cancer (PRIMM Study)
Lead sponsor
University Medical Centre Maribor
Phase
Phase 2
Overall status
Completed
Start date
July 14, 2022
Completion date
September 1, 2025
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung, metastatic lung non-small cell carcinoma, non small cell lung cancer